- 1Shanghai University of Traditional Chinese Medicine, Shanghai, China
- 2The Research Institute for Joint Diseases, Shanghai Academy of Traditional Chinese Medicine, Shanghai, China
- 3Jiangxi University of Traditional Chinese Medicine Affiliated Hospital, Nanchang, China
- 4Shanghai Guanghua Hospital of Integrative Medicine, Shanghai, China
By A X, Xin P, Zheng L, Xu B, Wang J, Sun S, Xie J, Gao C, Pan P, Qiu G, Jin L, Shen J, Xu X, Cheng Y, Pei S, Ran L, Bian Y and Xiao L (2026). Front. Immunol. 16:1691663. doi: 10.3389/fimmu.2025.1691663
An incorrect number was provided for the National Natural Science Foundation of China. The correct number is “(82474302)”.
The funder the Changning National Master of Traditional Chinese Medicine Studio was erroneously omitted. The Funding statement has been corrected to read:
“The author(s) declared that financial support was received for this work and/or its publication. This work was funded by the National Natural Science Foundation of China (82474302), Changning District Science and Technology Commission (CNKW2024Y19), the Training Program for High-caliber Talents of Clinical Research at Affiliated Hospital of SHUTCM (2023LCRC24), Shanghai Municipal Health Commission (20244Y0010), Scientific Research Project of Changning District Science and Technology Commission (CNKW2022Y22) and Shanghai Science and Technology Commission Support Project (23Y11921900), and was also supported by the Changning National Master of Traditional Chinese Medicine Studio”.
The original version of this article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: DNA methylation, gene expression, glycolysis, Mendelian randomization, multi-omics, PKD1, rheumatoid arthritis, SLC2A4
Citation: A X, Xin P, Zheng L, Xu B, Wang J, Sun S, Xie J, Gao C, Pan P, Qiu G, Jin L, Shen J, Xu X, Cheng Y, Pei S, Ran L, Bian Y and Xiao L (2026) Correction: Integrative multi-omics analyses identify PKD1 and SLC2A4 as genetically supported glycolysis-related candidate genes for rheumatoid arthritis. Front. Immunol. 17:1793746. doi: 10.3389/fimmu.2026.1793746
Received: 22 January 2026; Accepted: 23 January 2026;
Published: 29 January 2026.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2026 A, Xin, Zheng, Xu, Wang, Sun, Xie, Gao, Pan, Qiu, Jin, Shen, Xu, Cheng, Pei, Ran, Bian and Xiao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Lei Ran, cmFuX2xlaUBmb3htYWlsLmNvbQ==; Yanqin Bian, eGlhb2JpYW41MDRAMTI2LmNvbQ==; Lianbo Xiao, eGlhb19saWFuYm9AMTYzLmNvbQ==
†These authors have contributed equally to this work and share first authorship
Xinyu A1,2†